Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)
Pharvaris (PHVS) posted Accumulated Expenses of $28.35 trillion for Q2 2026, compared with $21.96 million a year earlier and up 27.1% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris' Accumulated Expenses came in at $26.38 trillion, up 38.6% from FY2024.
- Annual Accumulated Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 38.9% (FY2020 to FY2025).
- In prior years, Pharvaris' Accumulated Expenses was $19.04 trillion in FY2024 (+59.0%), $11.97 trillion in FY2023 (+4.3%), $11.48 trillion in FY2022 (+127.2%) and $5.05 trillion in FY2021 (-0.9%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2019.
- On a year-over-year basis, Accumulated Expenses increased in three of the last six quarters, with an average decline of 31.9%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2022, with growth of 137.5%; the weakest was Q2 2025, with a decline of 100.0%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $22.3 trillion (Q1 2026), $27.18 trillion (Q4 2025) and $26.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Pharvaris | 2.22 Bn | 841.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.86 Mn |
| Mar 31, 2026 | 21.83 Mn |
| Dec 31, 2025 | 27.43 Mn |
| Sep 30, 2025 | 26.61 Mn |
| Jun 30, 2025 | 22.75 Mn |
| Mar 31, 2025 | 18.58 Mn |
| Dec 31, 2024 | 18.30 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 13.11 Mn |
| Dec 31, 2023 | 12.25 Mn |
| Sep 30, 2023 | 12.13 Mn |
| Jun 30, 2023 | 11.13 Mn |
| Mar 31, 2023 | 10.78 Mn |
| Dec 31, 2022 | 11,610.36 Bn |
| Sep 30, 2022 | 9.96 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 7.29 Mn |
| Dec 31, 2021 | 4,835.88 Bn |
| Sep 30, 2021 | 4.23 Mn |
API Access
Pharvaris Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();